Skip to main content

Advertisement

SpringerLink
Log in

Gastric Carcinoma—a New Biomarker Peritoneal Fluid Lavage Cytology

  • Original Article
  • Published:
Indian Journal of Surgery Aims and scope Submit manuscript

Abstract

Presence of free gastric cancer cells in the peritoneal cavity of patients who undergo surgical treatment for gastric cancer is considered as a negative prognostic factor. It manifests as peritoneal metastasis and causes rapid recurrence of diseases. The aim of this study was to analyse factors associated with positive peritoneal cytology and identify patients in whom diagnostic peritoneal lavage could affect therapeutic decisions. The study enrolled patients with gastric cancer who underwent surgical treatment at the Department of General and Minimal Invasive Surgery, Sher-i-Kashmir Institute of Medical Sciences, Srinagar, over a period of 18 months from November of 2017 to May of 2019. During the laparotomy, 200 mL of physiological saline at 37 °C was administered in the tumour region. About 100 mL fluid was recovered from several regions of the abdominal cavity which was sent to the Department of Pathology where the samples were processed by liquid-based cytology technique. Results of peritoneal cytology were analysed jointly on the basis of clinical and pathological factors. Analysis of the peritoneal fluid for presence of free cancer cells was done in 52 patients. Positive peritoneal cytology was found in 9 (17.3%) patients. In the group of patients with positive cytology, all patients had T4 tumours and all were found to have lymph node metastases, whilst as grade 3 cancer was found in 55.5% patients. In patients with positive cytology, diffuse gastric cancer was seen in 7 out of 9 patients (77.7%), whilst in patients with negative cytology, intestinal type was seen in 41 of 43 patients (95.3%). Amongst the 9 patients with positive peritoneal cytology, 7 (77.7%) patients had tumour located in the distal part, and one (11.1%) patient had tumour located in the proximal part, whilst the lone patient with diffuse involvement of the stomach was also positive for malignant peritoneal cells. Based on this study, we can conclude that determinants of positive peritoneal cytology include tumour stage (T4), positive nodal status (N +). Knowing the peritoneal cytology status can alter the treatment strategy and can vary from curative to a palliative one and vice versa.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Ferro A, Peleteiro B, Malvezzi M, Bosetti C, Bertuccio P, Levi F et al (2014) Worldwide trends in gastric cancer mortality (1980–2011), with predictions to 2015, and incidence by subtype. Eur J Cancer 50:1330–1344

    Article  PubMed  Google Scholar 

  2. Sasako M, Sakuramoto S, Katai H, Kinoshita T, Furukawa H, Yamaguchi T et al (2011) Five-year outcomes of a randomized phase III trial comparing adjuvant chemotherapy with S-1 versus surgery alone in stage II or III gastric cancer. J Clin Oncol 29:4387–4393

    Article  CAS  PubMed  Google Scholar 

  3. Pavithran K, Doval DC, Pandey KK (2002) Gastric cancer in India. Gastric Cancer 5:240–243

    Article  PubMed  Google Scholar 

  4. Henson DE, Dittus C, Younes M, Nguyen H, Albores-Saavedra J (2004) Differential trends in the intestinal and diffuse types of gastric carcinoma in the United States, 1973–2000: increase in the signet ring cell type. Arch Pathol Lab Med 128:765–770

    Article  PubMed  Google Scholar 

  5. Avital I, Pisters PWT, Kelsen DP, Willett CG (2011) Cancer of the stomach. DeVita VT, Lawrence TS, Rosenberg SA. DeVita, Hellman, and Rosenberg’s cancer: principles and practice of oncology. 9th ed. Philadelphia: Lippincott Williams & Wilkins, pp 924–54

  6. National Comprehensive Cancer Network.(2016) NCCN Clinical practice guidelines in oncology: gastric cancer. Version 3

  7. Waddell T, Verheij M, Allum W, Cunningham D, Cervantes A, Arnold D. Gastric cancer: ESMO-ESSO-ESTRO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol Suppl 6:vi57–63

  8. Stomach. Edge SB, Byrd DR, Compton CC, et al (2002) AJCC Cancer staging manual. 7th ed. New York: Springer,p 120

  9. Bozzetti F, Marubini E, Bonfanti G, Miceli R, Piano C, Gennari L (1999) Subtotal versus total gastrectomy for gastric cancer: five-year survival rates in a multicenter randomized Italian trial. Italian Gastrointestinal Tumor Study Group. Ann Surg 230(2):170–8

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Bonenkamp JJ, Hermans J, Sasako M, van de Velde CJ, Welvaart K, Songun I, et al. van de Velde, CJ (1999) Extended lymph node dissection for gastric cancer. N Engl J Med 340:908

  11. Hartgrink HH, van de Velde CJ, Putter H, Bonenkamp JJ, Klein Kranenbarg E, Songun I et al (2004) Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch gastric cancer group trial. J Clin Oncol 22(11):2069–2077

    Article  CAS  PubMed  Google Scholar 

  12. Nakajima T, Nishi M, Kajitani T (1991) Improvement in treatment results of gastric cancer with surgery and chemotherapy: experience of 9700 cases in the Cancer Institute Hospital. Tokyo Semin Surg Oncol 7:365–372

    Article  CAS  PubMed  Google Scholar 

  13. Fuchs CS, Mayer RJ (1995) Gastric carcinoma. N Engl J Med 333:32–41

    Article  CAS  PubMed  Google Scholar 

  14. Maekawa S, Saku M, Maehara Y et al (1996) Surgical treatment for advanced gastric cancer. Hepatogastroenterology 43:178–186

    CAS  PubMed  Google Scholar 

  15. Iitsuka Y, Shiota S, Matsui T et al (1990) Relationship between the cytological characteristics of intraperitoneal free cancer cells and the prognosis in patients with gastric cancer. Acta Cytol 34:437–442

    CAS  PubMed  Google Scholar 

  16. Ikeguchi M, Oka A, Tsujitani S et al (1994) Relationship between area of serosal invasion and intraperitoneal free cancer cells in patients with gastric cancer. Anticancer Res 14:2131–2134

    CAS  PubMed  Google Scholar 

  17. Bentrem D, Wilton A, Mazumdar M et al (2005) The value of peritoneal cytology as a preoperative predictor in patients with gastric carcinoma undergoing a curative resection. Ann Surg Oncol 12(5):1–7

    Article  Google Scholar 

  18. Kodera Y, Yamamura Y, Shimizu Y, et al (1999) Peritoneal washing cytology: prognostic value of positive findings in patients with gastric carcinoma undergoing a potentially curative resection. J Surg Oncol 72(2):60–4 (discussion 4–5).

  19. Nath J, Moorthy K, Taniere P, Hallissey M, Alderson D (2008) Peritoneal lavage cytology in patients with oesophagogastric adenocarcinoma. Br J Surg 95:721–726

    Article  CAS  PubMed  Google Scholar 

  20. Hayes N, Wayman J, Wadehra V et al (1999) Peritoneal cytology in the surgical evaluation of gastric carcinoma. Br J Cancer 79:520–524

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Abe S, Yoshimura H, Tabara H et al (1995) Curative resection of gastric cancer: limitation of peritoneal lavage cytology in predicting the outcome. J Surg Oncol 59(4):226–229

    Article  CAS  PubMed  Google Scholar 

  22. Iitsuka Y, Kaneshima S, Tanida O et al (1979) Intraperitoneal free cancer cells and their viability in gastric cancer. Cancer 44:1476–1480

    Article  CAS  PubMed  Google Scholar 

  23. La Torre M, Ferri M, Giovagnoli MR et al (2010) Peritoneal wash cytology in gastric carcinoma. Prognostic significance and therapeutic consequences. Eur J Surg Oncol 36:982e986

  24. Hiratsuka M, Furukawa H, Iwanaga T, et al (1998) Peritoneal lavagecytology and intraperitoneal chemotherapy. In: Yonemura, ed. Peritoneal dissemination. Molecular mechanisms and the latest therapy. Kanazawa, Japan: Maeda Shoten, pp 201–214.

  25. Bonenkamp JJ, Songun I, Hermans J, van de Velde CJ (1996) Prognostic value of positive cytology findings from abdominal washings in patients with gastric cancer. br J Surg 83:672–74

    Article  CAS  PubMed  Google Scholar 

  26. Koga S, Kaibara N, Iitsuka Y et al (1984) Prognostic significance of intraperitoneal free cancer cells in gastric cancer patients. Cancer Res Clin Oncol 108:236–238

    Article  CAS  Google Scholar 

  27. Radosław Lisiecki, Arkadiusz Spychała, Katarzyna Pater, Dawid Murawa (2015) Analysis of risk factors of positive peritoneal cytology in patients treated for gastric cancer Polski Przegląd Chirurgiczny 87(10): 506–512

  28. Mezhir JJ, Shah MA, Jacks LM, Brennan MF, Coit DG, Strong VE (2010) Positive peritoneal cytology in patients with gastric cancer: natural history and outcome of 291 patients. Ann Surg Oncol 17(12):3173–3180

    Article  PubMed  Google Scholar 

  29. Nakajima T, Harashima S, Hirata M, Kajitani T (1978) Prognostic and therapeutic values of peritoneal cytology in gastric cancer. Acta Cytol 22:225–229

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of General and Minimal Invasive Surgery, SKIMS, Srinagar, Jammu and Kashmir, India

    Taifoor Aali Mir, Ajaz Ahmad Malik, Munir Ahmad Wani & Shams ul Bari

  2. Department of Pathology, SKIMS, Srinagar, Jammu and Kahmir, India

    Zubaida Rasool

Authors
  1. Taifoor Aali Mir
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ajaz Ahmad Malik
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Munir Ahmad Wani
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Zubaida Rasool
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Shams ul Bari
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Shams ul Bari.

Ethics declarations

Conflict of Interest

The authors declare no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mir, T.A., Malik, A.A., Wani, M.A. et al. Gastric Carcinoma—a New Biomarker Peritoneal Fluid Lavage Cytology. Indian J Surg 85, 76–82 (2023). https://doi.org/10.1007/s12262-022-03386-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12262-022-03386-4

Keywords

Search

Navigation